Detalhe da pesquisa
1.
Association Between T2-related Comorbidities and Effectiveness of Biologics in Severe Asthma.
Am J Respir Crit Care Med;
209(3): 262-272, 2024 Feb 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38016003
2.
Exploring Definitions and Predictors of Severe Asthma Clinical Remission Post-Biologic in Adults.
Am J Respir Crit Care Med;
2024 May 03.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38701495
3.
Non-parametric inference on calibration of predicted risks.
Stat Med;
2024 Jun 11.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38863133
4.
Cost-effectiveness of budesonide-formoterol vs inhaled epinephrine in US adults with mild asthma.
Ann Allergy Asthma Immunol;
132(2): 229-239.e3, 2024 Feb.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37879568
5.
Analysis of comorbidities and multimorbidity in adult patients in the International Severe Asthma Registry.
Ann Allergy Asthma Immunol;
132(1): 42-53, 2024 Jan.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37640263
6.
Impact of pre-biologic impairment on meeting domain-specific biologic responder definitions in patients with severe asthma.
Ann Allergy Asthma Immunol;
132(5): 610-622.e7, 2024 May.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38151100
7.
Impact of surgical lung biopsy on lung function and survival in patients with idiopathic pulmonary fibrosis in a multi-centre registry cohort.
Respirology;
2024 Mar 04.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38436522
8.
QRISK3 underestimates the risk of cardiovascular events in patients with COPD.
Thorax;
2023 Nov 27.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38050168
9.
Eligibility criteria from pharmaceutical randomised controlled trials of idiopathic pulmonary fibrosis: a registry-based study.
Eur Respir J;
61(5)2023 05.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36858445
10.
Can we predict who will benefit most from biologics in severe asthma? A post-hoc analysis of two phase 3 trials.
Respir Res;
24(1): 120, 2023 May 02.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37131185
11.
Comparative effectiveness of anti-IL5 and anti-IgE biologic classes in patients with severe asthma eligible for both.
Allergy;
78(7): 1934-1948, 2023 07.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36929509
12.
Trends in hospital admissions for chronic obstructive pulmonary disease over 16 years in Canada.
CMAJ;
195(35): E1172-E1179, 2023 09 11.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37696554
13.
Role of latent tuberculosis infection on elevated risk of cardiovascular disease: a population-based cohort study of immigrants in British Columbia, Canada, 1985-2019.
Epidemiol Infect;
151: e68, 2023 04 17.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37066967
14.
Pandemic Effect on Healthcare Use and Death in Adults with Epilepsy: A Population Study.
Can J Neurol Sci;
: 1-11, 2023 Dec 20.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38115804
15.
A parametric model to jointly characterize rate, duration, and severity of exacerbations in episodic diseases.
BMC Med Inform Decis Mak;
23(1): 6, 2023 01 12.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36635713
16.
Risk and distribution of chronic obstructive pulmonary disease-related hospitalizations among primary care patients.
Can Fam Physician;
69(6): 409-414, 2023 06.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37315968
17.
Benefit-harm analysis of azithromycin for the prevention of acute exacerbations of chronic obstructive pulmonary disease.
Thorax;
77(11): 1079-1087, 2022 11.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34836921
18.
Prevalence and characteristics of progressive fibrosing interstitial lung disease in a prospective registry.
Eur Respir J;
60(4)2022 10.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35273032
19.
Marginal Versus Conditional Odds Ratios When Updating Risk Prediction Models.
Epidemiology;
33(4): 555-558, 2022 07 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35394467
20.
Healthcare Costs for Pneumococcal Disease in the Era of Infant Immunization With 13-Valent Pneumococcal Conjugate Vaccine: A Population-Based Study.
Value Health;
25(9): 1510-1519, 2022 09.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35466049